Verification evidence is still being completed.
PDF / print export
Atrandi Biosciences
Vilnius, Lithuania
- Verified lead
- Juozas Nainys
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Single-cell Analysis
- Review cycle
- May 2026
- Full address
- Atradimų aklg. 7-101, LT-02301 Vilnius, Lithuania
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Atrandi leadership page confirming Juozas Nainys as CEO and co-founder.
- Editorial note
- Microfluidics and droplet-technology node supporting single-cell workflows, assay miniaturization, and advanced instrument integration.
Single-cell Analysis
ISO 9001:2015, R&D Focused
Microfluidics and droplet-technology node supporting single-cell workflows, assay miniaturization, and advanced instrument integration.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Vilnius, Lithuania
Atrandi Biosciences
Single-cell Analysis · Micro-scale
Microfluidics and droplet-technology node supporting single-cell workflows, assay miniaturization, and advanced instrument integration.
- Lead
- Juozas Nainys (verified ↗)
- Address
- Atradimų aklg. 7-101, LT-02301 Vilnius, Lithuania (source ↗)
- Compliance
- ISO 9001:2015
- Last reviewed
- 14 Mar 2026 (3mo ago)
- Scale
- Micro-scale
- Capabilities
- Droplet Microfluidics · Single-cell RNA-seq · High-throughput Screening
- Founded
- 2016
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Juozas Nainys
Chief Executive Officer and Co-Founder
Full addressAtradimų aklg. 7-101, LT-02301 Vilnius, Lithuania
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Atrandi about page listing the Vilnius headquarters at Atradimų aklg. 7-101.
Open sourceMicro-scale
Vilnius, Lithuania. Single-cell Analysis. Review completed on 14 Mar 2026.
State Health Care Accreditation Agency
ISO 9001:2015, R&D Focused
Single-cell Analysis
Microfluidics and droplet-technology node supporting single-cell workflows, assay miniaturization, and advanced instrument integration.
Editorial note
Atrandi is published as a live Vilnius life-science tools company with current founder-led management, a documented headquarters address, and a visible commercial single-cell product platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Droplet Microfluidics
Single-cell RNA-seq
High-throughput Screening
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Microfluidic Controllers
Fluorescence microscopes
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Atrandi Biosciences located?
- Atrandi Biosciences operates from Atradimų aklg. 7-101, LT-02301 Vilnius, Lithuania, Vilnius, Lithuania.
- Who runs Atrandi Biosciences?
- Atrandi Biosciences is led by Juozas Nainys, Chief Executive Officer and Co-Founder. Verified 14 Mar 2026.
- What certifications does Atrandi Biosciences hold?
- Atrandi Biosciences is documented under ISO 9001:2015.
- What does Atrandi Biosciences do?
- Microfluidics and droplet-technology node supporting single-cell workflows, assay miniaturization, and advanced instrument integration. Core capabilities: Droplet Microfluidics, Single-cell RNA-seq, High-throughput Screening.
Editorial context
Related technical briefs
Briefs that name Vilnius as a covered market or city.